SCHEMBL2483306

SCHEMBL2483306

Cc1cc(C2CCCC2)cc(OC(=O)c2ccccc2)c1OC(=O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
STAT3 P40763 2/20 0.43
CYP1A2 P05177 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMO O15229 1/20 0.43
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
SLC18A3 Q16572 1/20 0.40
SLC6A3 Q01959 1/20 0.40
PDE4B Q07343 3/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
MDM2 Q00987 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2483345 0.99 KMO (0.45) KMT2ASTAT3CYP1A2ALDH1A1CYP2C9
SCHEMBL2484027 0.86 KMT2A (0.44) KMT2ASTAT3CYP1A2ALDH1A1CYP2C9
SCHEMBL2507825 0.85 KMT2A (0.42) KMT2ASTAT3CYP1A2ALDH1A1CYP2C9
SCHEMBL2482272 0.85 KMO (0.46) KMT2ASTAT3CYP1A2ALDH1A1CYP2C9
SCHEMBL2484042 0.85 KMO (0.46) KMT2ASTAT3CYP1A2ALDH1A1CYP2C9
SCHEMBL2507641 0.85 KMO (0.46) KMT2ASTAT3CYP1A2ALDH1A1CYP2C9
SCHEMBL2507453 0.84 KMT2A (0.41) KMT2ASTAT3CYP1A2ALDH1A1CYP2C9
SCHEMBL2509821 0.84 KMO (0.43) KMT2ASTAT3CYP1A2ALDH1A1CYP2C9
SCHEMBL2481850 0.84 KMT2A (0.43) KMT2ASTAT3CYP1A2ALDH1A1CYP2C9
SCHEMBL2507634 0.83 KMO (0.42) KMT2ASTAT3CYP1A2ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT KMT2A 1611/4885STAT3 3071/4885CYP1A2 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.